Elections › Corporate Influence › AMGEN INC.

🏛️ AMGEN INC.

CORPORATE LOBBYING & ELECTION INFLUENCE PROFILE

$22.9M
Lobbying Spend
$0
Campaign Spending
93
Lobbyists
0
Races Influenced
106
LDA Filings
Lobbying Issue Areas
🏥 Healthcare & Pharma🏭 Trade & Manufacturing🤖 Tech & AI🛡️ Defense & Security
Filing Quarters
first_quarterfourth_quartersecond_quarterthird_quarter
Specific Lobbying Issues
Issues related to Part D rebates Proposals related to drug pricing, drug price transparency, PBMS Implementation of the Inflation Reduction Act
Issues related to the pharmaceutical industry.
IRA, 340B, biosimilars, orphan drugs, prescription drug access & reimbursement, FDA issues, transparency
Medicare coverage and reimbursement issues, Medicare Part B reimbursement, transparency, prescription drug pricing and access, 340B
federal budget issues
Where the Money Is Going
Race Campaign $ Candidate(s)
No race-level spending data linked yet.
Source: Senate LDA lobbying disclosures + FEC campaign finance data + USAspending.gov via Hammerhead Intelligence
Lobbying $ = annual reported federal lobbying expenditures (company-wide). Campaign $ = IE spending directed at candidates in specific races. Govt Contracts $ = federal awards from USAspending.gov.
Last updated: 2026-04-25